logo

For the Inventor, By the Inventor

Peabody, MA, United States of America

Progeria Research Foundation, Inc.


USPTO Granted Patents = 11

% Expired Patents = 54.5


Trademarks = 6

Forward Citations = 10

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Leslie B Gordon (11 out of 14 patents)

silverMedal Francis S Collins (11 out of 31 patents)

bronzeMedal Adrienne Cox (4 out of 5 patents)

4.  Thomas Glover (4 out of 4 patents)

5.  Michael W Glynn (4 out of 6 patents)

6.  Brian C Capell (4 out of 4 patents)

7.  B Maria H Eriksson (4 out of 4 patents)

8.  Channing J Der (4 out of 11 patents)

9.  Kan Cao (3 out of 7 patents)

10.  Michael R Erdos (3 out of 5 patents)

11.  Ryszard M Kole (3 out of 29 patents)

12.  W Ted Brown (3 out of 3 patents)

13.  Richard Keith Bestwick (2 out of 36 patents)

14.  William Ted Brown (1 out of 3 patents)

15.  Adrienne D c/o Dept Radiation Oncology Cox (0 patent)


11 patents:

1. 11802283 - Oligonucleotide analogues targeting human LMNA (2023-10-31),
2. 10822608 - Oligonucleotide analogues targeting human LMNA (2020-11-03),
3. 10398721 - Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA (2019-09-03),
4. 9115400 - [object Object] (2015-08-25),
5. 8828356 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2014-09-09),
6. 8691501 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2014-04-08),
7. 8535884 - [object Object] (2013-09-17),
8. 8257915 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2012-09-04),
9. 8034557 - LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis (2011-10-11),
10. 7838531 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2010-11-23),
11. 7297492 - LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis (2007-11-20),
Company Overview
The Progeria Research Foundation, Inc. is dedicated to understanding and treating Hutchinson-Gilford Progeria Syndrome, a rare genetic condition characterized by accelerated aging in children. The foundation focuses on advancing research and developing therapeutic strategies to improve the quality of life for affected individuals. Based in Peabody, MA, the organization collaborates with scientists and medical professionals globally to foster innovation in genetic research and treatment methodologies, aiming to unlock insights that may benefit broader aging-related studies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#9 in Peabody, MA

#1,661 in Massachusetts

#27,490 in US

#51,714 in the World

Peabody, MA (US)
Peabody, MA, United States of America

Progeria Research Foundation, Inc.

Forward Citations = 10

14 inventors:

goldMedal Leslie B Gordon (11 out of 14 patents)

silverMedal Francis S Collins (11 out of 31 patents)

bronzeMedal Adrienne Cox (4 out of 5 patents)

4.  Thomas Glover (4 out of 4 patents)

5.  Michael W Glynn (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Progeria Research Foundation, Inc.. Retrieved from https://idiyas.com/company/progeria-research-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…